Literature DB >> 10667814

Study of survival and prognostic factors in patients undergoing resection for gastric linitis plastica: a review of 86 cases.

A Hamy1, E Letessier, P Bizouarn, J Paineau, G Aillet, E Mirallié, J Visset.   

Abstract

A retrospective study was conducted in a series of 86 patients (51 men and 35 women; mean age 63.4 years) treated from 1979 to 1995 for linitis plastica of the stomach (LP). The mean interval between the first manifestations and surgery was 3.5 months. The most frequent clinical sign was epigastric pain which occurred in 80.4% of cases. Biopsies were positive in 75.6% of cases. Typical features of LP were found in only 46% of esogastric barium enemas and 11.8% of upper gastrofiberscopic examinations. Seventy-four patients had surgical excision (51 total and 23 partial gastrectomies). There were 6 (7%) postoperative deaths and 10 (11.6%) surgical complications. Node involvement was found in 54 (72.9%) patients. Overall actuarial survival (n = 86) was 50% at 12 months, 40% at 18 months and 7.5% at 84 months. Survival did not depend on the delay in diagnosis, histological analysis of the extremities of the excised piece, associated tissue differentiation, node involvement or the type of surgical excision. The prognosis differed according to tumor height (P<0.01) and involvement of the deep stomach wall (P<0.001). No independent prognostic factor was found in multivariate analysis. Surgery remains the sole possibility for curative therapy in these patients.

Entities:  

Mesh:

Year:  1999        PMID: 10667814

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  9 in total

1.  An Insufficient Preoperative Diagnosis of Borrmann Type 4 Gastric Cancer in Spite of EMR.

Authors:  Jae Bong Ahn; Tae Kyung Ha; Hang Rak Lee; Sung Joon Kwon
Journal:  J Gastric Cancer       Date:  2011-03-31       Impact factor: 3.720

2.  A leathery lining.

Authors:  Rushi V Parikh; Nicholas Frost; Adrienne Green; Madhavi Dandu
Journal:  J Gen Intern Med       Date:  2013-07-17       Impact factor: 5.128

3.  Gastric linitis plastica: which role for surgical resection?

Authors:  Corrado Pedrazzani; Daniele Marrelli; Fabio Pacelli; Maria Di Cosmo; Gianni Mura; Francesca Bettarini; Fausto Rosa; Giovanni de Manzoni; Franco Roviello
Journal:  Gastric Cancer       Date:  2011-06-30       Impact factor: 7.370

4.  Survival following operative management of gastric linitis plastica compared with non-operative management.

Authors:  R J Thompson; L Ranaghan; R Kennedy; Wdb Clements; P D Carey; J A Kennedy
Journal:  Ann R Coll Surg Engl       Date:  2016-11-04       Impact factor: 1.891

5.  Borrmann type IV: an independent prognostic factor for survival in gastric cancer.

Authors:  Ji Yeong An; Tae Ho Kang; Min Gew Choi; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  J Gastrointest Surg       Date:  2008-05-31       Impact factor: 3.452

6.  Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative.

Authors:  Aaron U Blackham; Doug S Swords; Edward A Levine; Nora F Fino; Malcolm H Squires; George Poultsides; Ryan C Fields; Mark Bloomston; Sharon M Weber; Timothy M Pawlik; Linda X Jin; Gaya Spolverato; Carl Schmidt; David Worhunsky; Clifford S Cho; Shishir K Maithel; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2015-11-03       Impact factor: 5.344

7.  [Bladder metastasis of signet ring gastric adenocarcinoma].

Authors:  Youssef Seddik; Ouissam Al Jarroudi; Sami Aziz Brahmi; Said Afqir
Journal:  Pan Afr Med J       Date:  2014-10-27

8.  The efficacy of treating patients with non-metastatic gastric linitis plastica using surgery with chemotherapy and/or radiotherapy.

Authors:  Xueru Song; Yan Shi; Tao Shi; Baorui Liu; Jia Wei; Jiping Wang
Journal:  Ann Transl Med       Date:  2020-11

Review 9.  The significance of a nineteenth century definition in the era of genomics: linitis plastica.

Authors:  Annamaria Agnes; Jeannelyn S Estrella; Brian Badgwell
Journal:  World J Surg Oncol       Date:  2017-07-05       Impact factor: 2.754

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.